Effective Surveillance

Antimicrobial resistance (AMR)

AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.

AMR Insights

For Officers at authorities, ministries, international organisations and NGO’s who wish to prevent the further global spreading of Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities. 

AMR Insights is for:

  • Senior officials and (top) civil servants at national authorities
  • Policy Officers at Ministries
  • Civil servants at regional authorities
  • Senior officials at international organizations
  • Senior officials at NGO’s

Latest Topics

  •   20 April 2026

    Distinct infant resistome trajectories shaped by country income and geography revealed through global metagenomics reanalysis

    A large meta-analysis of 1,944 infant gut metagenomes shows that antimicrobial resistance gene (ARG) patterns diverge early in life and are strongly shaped by socioeconomic and clinical factors. While ARG levels are similar across income settings in the first three months, by six months infants in low-income countries exhibit significantly higher ARG abundance, closely associated […]

    Read more...
  •   20 April 2026

    Emergence of Extensively Drug-Resistant Shigellosis — United States, 2011–2023

    The Centers for Disease Control and Prevention MMWR report (Vol. 75, No. 13) documents a concerning rise of extensively drug-resistant (XDR) Shigella infections in the United States between 2011 and 2023: the proportion of isolates classified as XDR increased from 0% to 8.5%, with these strains resistant to all commonly used first-line antibiotics and no […]

    Read more...
  •   17 April 2026

    Antimicrobial resistance as an economic externality: optimal control, Pigouvian taxation, and governance implications

    Antimicrobial resistance (AMR) poses a growing global health and economic threat, driven in part by misaligned incentives across healthcare, agriculture, and trade. This study uses a dynamic economic model to analyse how antibiotic use, resistance development, and societal costs interact, and evaluates policy interventions based on European data. The findings suggest that optimal antibiotic use […]

    Read more...

More news related to Effective surveillance

Please call me back

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!